Lil­ly’s pipeline drug re­ta­tru­tide sets new thresh­old for weight loss at med­ical meet­ing re­veal

Eli Lil­ly’s ex­per­i­men­tal weight loss drug ap­pears to have set a new bar, help­ing obese pa­tients in a Phase II study lose 24% of their …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.